Sep 2026
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
G. S. Guru Murthy, B. Shah, Talha Badar et al.
· Leukemia · 0 citations